| Identification | |
| Name: | Ezetimibe |
| Synonyms: | (-)-Sch 58235;Zetia (TN);Zetia;Ezetimibe 1-(4-flurophenyl)-(3R)-[3-(4-flurophenyl)-(3S)-hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone;2-Azetidinone,1-(4-fluorophenyl)-3-[(3S)-3- (4-fluorophenyl)-3-hydroxypropyl]-4-(4- hydroxyphenyl)-,(3R,4S)-;Sch 58235;Vytorin;Ezedoc;(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone; |
| CAS: | 163222-33-1 |
| Molecular Formula: | C24H21F2NO3 |
| Molecular Weight: | 409.43 |
| InChI: | InChI=1/C24H21F2NO3/c25-17-5-1-15(2-6-17)22(29)14-13-21-23(16-3-11-20(28)12-4-16)27(24(21)30)19-9-7-18(26)8-10-19/h1-12,21-23,28-29H,13-14H2/t21-,22+,23-/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.334g/cm3 |
| Refractive index: | 1.623 |
| Solubility: | In water, 4.4 mg/L at 25 deg C (est) |
| Appearance: | white powder |
| Specification: | Patient monitoring: 1)Monitor hepatic and lipid profiles 2)Assess for and report unexplained muscle pain. |
| Color: | White solid |
| Usage: | Ezetimibe is an anti-hyperlipidemic medication which is used to lower Cholesterol levels. It acts by decreasing Cholesterol absorption in the intestine. It could be used alone when other Cholesterol-lowering medications are not tolerated, or when Cholesterol levels are unable to be controlled on statins alone, ezetimibe could be used together with statins |
| Safety Data | |
 |
|
